[ad_1] A big part of investing in biotech is owning takeover names. The quick gains…
Cancer Drugs
-
-
STOCK MARKET
Retired doctor known as the ‘yellow man’ sentenced for selling toxic chemical as weight-loss drug that killed customer
by userby user[ad_1] Retired New Jersey doctor William Merlino spent his golden years selling weight-loss drugs online.…
-
[ad_1] AstraZeneca PLC said Tuesday it was disappointed with the outcome of the U.S. Food…
-
STOCK MARKET
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
by userby user[ad_1] Strong sales of blockbuster drugs Keytruda and Gardasil helped Merck & Co. Inc. post…
-
STOCK MARKET
Coca-Cola stock rises on forecast-beating results; Bed Bath & Beyond shares slump and other stocks on the move
by userby user[ad_1] Here are some of the biggest stock movers in premarket trading on Monday, as…
-
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…
-
STOCK MARKET
Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise
by userby user[ad_1] A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising…
-
STOCK MARKET
New blood test promises to detect cancerous tumors before they are formed
by userby user[ad_1] The future of cancer treatment — hailed as the “holy grail” of early detection…
-
[ad_1] Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary…
-
STOCK MARKET
Pfizer’s $43 billion bid for Seagen aims to broaden company’s cancer portfolio
by userby user[ad_1] Pfizer’s PFE, +1.50% proposed acquisition of Seagen SGEN, +15.29%, which develops cancer treatments, for…